Venclexta/rituximab (venetoclax/rituximab)

pCPA File Number: 21136
Negotiation Status:
Concluded with an LOI
Indication(s):
Chronic Lymphocytic Leukemia
Sponsor/Manufacturer:
AbbVie Corporation
CADTH Project Number:
pCODR 10162
pCPA Engagement Letter Issued:
Negotiation Process Concluded: